Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Etrasimod is a new type of oral medication called an Sphingosine-1-phosphate (S1P) receptor modulators. It's used to treat inflammatory bowel diseases and is an important new option for treating ulcerative colitis (UC) (1, 2, 3).
The FDA and EMA have approved Etrasimod for adults with moderate to severe ulcerative colitis (2, 4).
Recently, Etrasimod showed positive results in the phase II OASIS study and it…